Gossamer Bio, Inc. financial data

Symbol
GOSS on Nasdaq
Industry
Pharmaceutical Preparations
Location
3115 Merryfield Row, Suite 120, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 723 % +22.4%
Debt-to-equity 577 % -55.4%
Return On Equity -118 % +87.5%
Return On Assets -17.4 % +74.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 227M shares +0.44%
Common Stock, Shares, Outstanding 227M shares +0.53%
Entity Public Float 197M USD +101%
Common Stock, Value, Issued 23K USD 0%
Weighted Average Number of Shares Outstanding, Basic 226M shares +48.2%
Weighted Average Number of Shares Outstanding, Diluted 226M shares +48.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.48M USD
General and Administrative Expense 36.1M USD -6.04%
Operating Income (Loss) -59.9M USD +67.4%
Nonoperating Income (Expense) 4.28M USD +8.68%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -31.9M USD +20.2%
Income Tax Expense (Benefit) -1.13M USD
Net Income (Loss) Attributable to Parent -56.5M USD +68.6%
Earnings Per Share, Basic -0.25 USD/shares +78.8%
Earnings Per Share, Diluted -0.25 USD/shares +78.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 46.1M USD +43.5%
Marketable Securities, Current 248M USD -6.01%
Accounts Receivable, after Allowance for Credit Loss, Current 5.34M USD
Assets, Current 310M USD +1.1%
Property, Plant and Equipment, Net 10K USD -99.4%
Operating Lease, Right-of-Use Asset 5.11M USD +63.2%
Other Assets, Noncurrent 283K USD -54.2%
Assets 315M USD +1.08%
Accounts Payable, Current 2.32M USD -58%
Employee-related Liabilities, Current 12M USD +16.5%
Accrued Liabilities, Current 15.2M USD -43.1%
Contract with Customer, Liability, Current 17.1M USD
Liabilities, Current 45M USD -12.8%
Contract with Customer, Liability, Noncurrent 38.9M USD
Operating Lease, Liability, Noncurrent 4.4M USD +2954%
Liabilities 286M USD +14.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.19M USD
Retained Earnings (Accumulated Deficit) -1.27B USD -4.66%
Stockholders' Equity Attributable to Parent 29.5M USD -53%
Liabilities and Equity 315M USD +1.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -52.3M USD +1.3%
Net Cash Provided by (Used in) Financing Activities -2.56M USD -0.75%
Net Cash Provided by (Used in) Investing Activities 61.7M USD +607%
Common Stock, Shares Authorized 700M shares 0%
Common Stock, Shares, Issued 227M shares +0.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.75M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 46.1M USD +43.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 367K USD -44.6%
Deferred Tax Assets, Valuation Allowance 229M USD +3.29%
Deferred Tax Assets, Gross 230M USD +3.43%
Operating Lease, Liability 5.36M USD +55.5%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55M USD +69.4%
Lessee, Operating Lease, Liability, to be Paid 7.06M USD +98.1%
Property, Plant and Equipment, Gross 193K USD -97.3%
Operating Lease, Liability, Current 961K USD -70.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.42M USD +884%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.55M USD -54.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure +71.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.7M USD +1352%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Deferred Tax Assets, Operating Loss Carryforwards 97.9M USD -20.4%
Unrecognized Tax Benefits 13.9M USD +1.94%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.45M USD
Operating Lease, Payments 3.8M USD +15.2%
Depreciation, Depletion and Amortization 833K USD -48.2%
Share-based Payment Arrangement, Expense 20.6M USD -27.7%
Interest Expense 13.1M USD -5.56%